1Eagle K,Ledermann J.Tumor markers in ovarian malignancies[J].Oncology,1997,2:324-9.
2Epiney M,Bertossa C,Weil A,et al.CA125 production by the peritoneum:in-vitro and in-vivo studies[J].Hum Reprod,2000,15(6):1261-5.
3Bischof P.What do we know about the origin of CA 125[J]? Eur J Obstet Gynecol Reprod Biol,1993,1-2:93-8.
4Nagele H,Bahlo M,Klapdor R,et al.CA-125 and its relation to cardiac function[J].Am Heart J,1999,137:1044-9.
5Devarbhavi H,Kaese D,Williams AW,et al.Cancer antigen 125 in patients with chronic liver disease[J].Mayo Clin Proc,2002,77(6):538-41.
6Yilmaz A,Ece F,Bayramgurler B,et al.The value of CA125 in the evaluation of tuberculosis activity[J].Respir Med,2001,95(8):666-9.
7Mas MR,Comert B,Saglamkaya U,et al.CA-125:a new marker for diagnosis and follow-up of patients with tuberculous peritonitis[J].Dig Liver Dis,2000,32(7):595-7.
8Zeimet AG,Marth C,Offner FA,et al.Human peritoneal mesothelial cells are more potent than ovarian cancer cells in producing tumor marker CA-125[J].Gynecol Oncol,1996,62:384-9.
2BAST R C Jr, KLUG T L, ST J E, et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer[J]. N Engl J Med, 1983, 309(15) :883 -887.
3MOSS E L, HOLLINGWORTH J, REYNOLDS T M. The role of CA125 in clinical practice [ J ]. J Clin Pathol, 2005,58(3) :308 -312.
4KABAWAT S E, BAST R C Jr, BHAN A K, et al. Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125 [ J ]. Int J Gynecol Pathol, 1983,2 (3) :275 - 285.
5ZIDAN J, HUSSEIN O, BASHER W, et al. Serum CA125: a tumor marker for monitoring response to treatment and follow-up in patients with non-Hodgkin's lymphoma [ J ]. Oncologist, 2004,9 ( 4 ) :417 - 421.
6CHAUBE A, TEWARI M, SINGH U, et al. CA 125: a potential tumor marker for gallbladder cancer [ J ]. J Surg Oncol, 2006,93 ( 8 ) :665 - 669.
7NAGELE H, BAHLO M, KLAPDOR R, et al. CA 125 and its relation to cardiac function [ J ]. Am Heart J, 1999,137(6) :1044 - 1049.
8DUMAN C, ERCAN E, TENGIZ I, et al. Elevated serum CA 125 levels in mitral stenotic patients with heart failure[ Jl. Cardiology, 2003,100( 1 ) :7 - 10.
9KOURIS N T, ZACHAROS I D, KONTOGIANNI D D, et al. The significance of CA125 levels in patients with chronic congestive heart failure. Correlation with clinical and echocardiographic parameters [ J ]. Eur J Heart Fail, 2005,7 (2) : 199 - 203.
10BARCELO B, AYLLON O, BELMONTE M, et al. Proposed reference value of the CA 125 tumour marker in men. Potential applications in clinical practice [ J ]. Clin Biochem, 2008,41 (9) :717 - 722.
